• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化导致人丙酮酸脱氢酶复合体失活的结构基础:无序磷酸化环的作用

Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.

作者信息

Kato Masato, Wynn R Max, Chuang Jacinta L, Tso Shih-Chia, Machius Mischa, Li Jun, Chuang David T

机构信息

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9038, USA.

出版信息

Structure. 2008 Dec 10;16(12):1849-59. doi: 10.1016/j.str.2008.10.010.

DOI:10.1016/j.str.2008.10.010
PMID:19081061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2849990/
Abstract

We report the crystal structures of the phosporylated pyruvate dehydrogenase (E1p) component of the human pyruvate dehydrogenase complex (PDC). The complete phosphorylation at Ser264-alpha (site 1) of a variant E1p protein was achieved using robust pyruvate dehydrogenase kinase 4 free of the PDC core. We show that unlike its unmodified counterpart, the presence of a phosphoryl group at Ser264-alpha prevents the cofactor thiamine diphosphate-induced ordering of the two loops carrying the three phosphorylation sites. The disordering of these phosphorylation loops is caused by a previously unrecognized steric clash between the phosphoryl group at site 1 and a nearby Ser266-alpha, which nullifies a hydrogen-bonding network essential for maintaining the loop conformations. The disordered phosphorylation loops impede the binding of lipoyl domains of the PDC core to E1p, negating the reductive acetylation step. This results in the disruption of the substrate channeling in the PDC, leading to the inactivation of this catalytic machine.

摘要

我们报道了人类丙酮酸脱氢酶复合体(PDC)的磷酸化丙酮酸脱氢酶(E1p)组分的晶体结构。使用不含PDC核心的活性丙酮酸脱氢酶激酶4实现了变体E1p蛋白Ser264-α(位点1)的完全磷酸化。我们发现,与未修饰的对应物不同,Ser264-α处存在磷酸基团会阻止辅因子硫胺二磷酸诱导的携带三个磷酸化位点的两个环的有序化。这些磷酸化环的无序化是由位点1处的磷酸基团与附近的Ser266-α之间先前未被认识的空间冲突引起的,这使维持环构象所必需的氢键网络无效。无序的磷酸化环阻碍了PDC核心的硫辛酰结构域与E1p的结合,使还原乙酰化步骤无效。这导致了PDC中底物通道的破坏,导致这种催化机制失活。

相似文献

1
Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.磷酸化导致人丙酮酸脱氢酶复合体失活的结构基础:无序磷酸化环的作用
Structure. 2008 Dec 10;16(12):1849-59. doi: 10.1016/j.str.2008.10.010.
2
Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases.磷酸化对哺乳动物丙酮酸脱氢酶复合体的调控:多个磷酸化位点和激酶的复杂性
Exp Mol Med. 2001 Dec 31;33(4):191-7. doi: 10.1038/emm.2001.32.
3
Pyruvate dehydrogenase complex deficiency is linked to regulatory loop disorder in the αV138M variant of human pyruvate dehydrogenase.丙酮酸脱氢酶复合物缺陷与人类丙酮酸脱氢酶αV138M 变体中的调节环紊乱有关。
J Biol Chem. 2018 Aug 24;293(34):13204-13213. doi: 10.1074/jbc.RA118.003996. Epub 2018 Jul 3.
4
Studies on the regulation of the mitochondrial alpha-ketoacid dehydrogenase complexes and their kinases.线粒体α-酮酸脱氢酶复合体及其激酶的调控研究。
Adv Enzyme Regul. 1997;37:271-93. doi: 10.1016/s0065-2571(96)00009-x.
5
A molecular switch and proton wire synchronize the active sites in thiamine enzymes.一种分子开关和质子线使硫胺素酶中的活性位点同步。
Science. 2004 Oct 29;306(5697):872-6. doi: 10.1126/science.1101030.
6
Phosphorylation of serine 264 impedes active site accessibility in the E1 component of the human pyruvate dehydrogenase multienzyme complex.丝氨酸264的磷酸化会阻碍人类丙酮酸脱氢酶多酶复合体E1组分中活性位点的可及性。
Biochemistry. 2007 May 29;46(21):6277-87. doi: 10.1021/bi700083z. Epub 2007 May 3.
7
Interactions of lipoyl domains with the E1p subunits of the pyruvate dehydrogenase multienzyme complex from Escherichia coli.硫辛酰结构域与大肠杆菌丙酮酸脱氢酶多酶复合物E1p亚基的相互作用。
FEBS Lett. 1990 Mar 26;262(2):241-4. doi: 10.1016/0014-5793(90)80200-3.
8
Subunit and catalytic component stoichiometries of an in vitro reconstituted human pyruvate dehydrogenase complex.体外重组人丙酮酸脱氢酶复合体的亚基和催化成分化学计量比
J Biol Chem. 2009 May 8;284(19):13086-98. doi: 10.1074/jbc.M806563200. Epub 2009 Feb 24.
9
Biochemistry. How active sites communicate in thiamine enzymes.
Science. 2004 Oct 29;306(5697):818-20. doi: 10.1126/science.1105457.
10
Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates.使用天然硫辛酰结构域底物的哺乳动物丙酮酸脱氢酶的反应机制。
Arch Biochem Biophys. 2001 Feb 15;386(2):123-35. doi: 10.1006/abbi.2000.2222.

引用本文的文献

1
Emerging roles of pyruvate dehydrogenase phosphatase 1: a key player in metabolic health.丙酮酸脱氢酶磷酸酶1的新作用:代谢健康的关键参与者
Front Physiol. 2025 May 26;16:1596636. doi: 10.3389/fphys.2025.1596636. eCollection 2025.
2
Sepsis-induced changes in pyruvate metabolism: insights and potential therapeutic approaches.脓毒症诱导的丙酮酸代谢变化:见解与潜在治疗方法。
EMBO Mol Med. 2024 Nov;16(11):2678-2698. doi: 10.1038/s44321-024-00155-6. Epub 2024 Oct 28.
3
Stoichiometry and architecture of the human pyruvate dehydrogenase complex.

本文引用的文献

1
Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity.丙酮酸脱氢酶激酶-4结构揭示了一种促进强大无核心基础活性的亚稳态开放构象。
J Biol Chem. 2008 Sep 12;283(37):25305-25315. doi: 10.1074/jbc.M802249200. Epub 2008 Jul 24.
2
PDC deletion: the way to a man's heart disease.
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H917-H919. doi: 10.1152/ajpheart.00663.2008. Epub 2008 Jul 18.
3
Crystal structure of pyruvate dehydrogenase phosphatase 1 and its functional implications.丙酮酸脱氢酶磷酸酶1的晶体结构及其功能意义
人类丙酮酸脱氢酶复合体的化学计量与结构
Sci Adv. 2024 Jul 19;10(29):eadn4582. doi: 10.1126/sciadv.adn4582. Epub 2024 Jul 17.
4
Mitochondrial Alpha-Keto Acid Dehydrogenase Complexes: Recent Developments on Structure and Function in Health and Disease.线粒体 α-酮酸脱氢酶复合物:在健康和疾病中的结构和功能的最新进展。
Subcell Biochem. 2024;104:295-381. doi: 10.1007/978-3-031-58843-3_13.
5
Sodium Metabisulfite Inhibits Trophozoite Growth through Thiamine Depletion.焦亚硫酸钠通过硫胺素耗竭抑制滋养体生长。
Pathogens. 2024 May 21;13(6):431. doi: 10.3390/pathogens13060431.
6
In Vitro and In Silico Studies on Cytotoxic Properties of Oxythiamine and 2'-Methylthiamine.关于氧化硫胺素和2'-甲基硫胺素细胞毒性特性的体外和计算机模拟研究
Int J Mol Sci. 2024 Apr 15;25(8):4359. doi: 10.3390/ijms25084359.
7
Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis.鉴定多发性骨髓瘤诊断的新型铜死亡相关基因特征。
Immun Inflamm Dis. 2023 Nov;11(11):e1058. doi: 10.1002/iid3.1058.
8
-Knockout Induces Abnormal Metabolic Phenotype via the Activation of Hepatic STAT5/PDK4 Signaling in Diabetic Mice.敲除通过激活糖尿病小鼠肝脏中的STAT5/PDK4信号通路诱导异常代谢表型。
Pathogens. 2023 Oct 30;12(11):1300. doi: 10.3390/pathogens12111300.
9
Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin.磷酸化丙酮酸脱氢酶与丙酮酸激酶M2的结合促进PKM2在胰岛素作用下的稳定性。
Int J Mol Sci. 2023 Sep 5;24(18):13697. doi: 10.3390/ijms241813697.
10
Analysis of cuproptosis-related genes in Ulcerative colitis and immunological characterization based on machine learning.基于机器学习的溃疡性结肠炎铜死亡相关基因分析及免疫特征研究
Front Med (Lausanne). 2023 Jul 17;10:1115500. doi: 10.3389/fmed.2023.1115500. eCollection 2023.
J Mol Biol. 2007 Jul 13;370(3):417-26. doi: 10.1016/j.jmb.2007.05.002. Epub 2007 May 10.
4
Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy.实体瘤中缺氧和缺氧诱导因子1(HIF1)的代谢靶向可增强细胞毒性化疗。
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9445-50. doi: 10.1073/pnas.0611662104. Epub 2007 May 15.
5
Phosphorylation of serine 264 impedes active site accessibility in the E1 component of the human pyruvate dehydrogenase multienzyme complex.丝氨酸264的磷酸化会阻碍人类丙酮酸脱氢酶多酶复合体E1组分中活性位点的可及性。
Biochemistry. 2007 May 29;46(21):6277-87. doi: 10.1021/bi700083z. Epub 2007 May 3.
6
Metabolic targeting as an anticancer strategy: dawn of a new era?代谢靶向作为一种抗癌策略:新时代的曙光?
Sci STKE. 2007 Apr 10;2007(381):pe14. doi: 10.1126/stke.3812007pe14.
7
The two active sites in human branched-chain alpha-keto acid dehydrogenase operate independently without an obligatory alternating-site mechanism.人类支链α-酮酸脱氢酶中的两个活性位点独立运作,不存在强制性的交替位点机制。
J Biol Chem. 2007 Apr 20;282(16):11904-13. doi: 10.1074/jbc.M610843200. Epub 2007 Feb 27.
8
Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.丙酮酸脱氢酶激酶的调节机制及其在治疗糖尿病、心脏缺血和癌症中的抑制作用。
Cell Mol Life Sci. 2007 Apr;64(7-8):830-49. doi: 10.1007/s00018-007-6380-z.
9
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.线粒体 - 钾离子通道轴在癌症中受到抑制,使其正常化可促进细胞凋亡并抑制癌症生长。
Cancer Cell. 2007 Jan;11(1):37-51. doi: 10.1016/j.ccr.2006.10.020.
10
Direct kinetic evidence for half-of-the-sites reactivity in the E1 component of the human pyruvate dehydrogenase multienzyme complex through alternating sites cofactor activation.通过交替位点辅因子激活,获得人类丙酮酸脱氢酶多酶复合体E1组分中半位点反应性的直接动力学证据。
Biochemistry. 2006 Oct 24;45(42):12775-85. doi: 10.1021/bi061582l.